MovDisordV3, PascalFrancis, Corpus, bibRecord, 001E83

Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report

Identifieur interne : 001E83 ( PascalFrancis/Corpus ); précédent : 001E82; suivant : 001E84

Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report

Auteurs : Masahiko Suzuki ; Nobutaka Hattori ; Satoshi Orimo ; Nobuyoshi Fukumitsu ; M. Masahiro Abo ; Yu Kono ; Renpei Sengoku ; Akira Kurita ; Hidehiko Honda ; Kiyoharu Inoue

Source :

Movement disorders [ 0885-3185 ] ; 2005.

RBID : Pascal:05-0281352

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Parkinsonisme, Parkinson maladie, Captation, Etude cas.

English descriptors

KwdEn :
- Case study, Nervous system diseases, Parkinson disease, Parkinsonism, Uptake.

Abstract

A decrease in myocardial uptake of iodine-123-labeled metaiodobenzylguanidine (¹²³I-MIBG) has been reported in idiopathic Parkinson's disease (PD) using ¹²³I-MIBG myocardial scintigraphy. However, the patient with autosomal recessive juvenile parkinsonism (AR-JP). caused by the parkin gene, presented here showed normal ¹²³I-MIBG myocardial uptake, suggesting that AR-JP is a distinct disease entity from PD. Although the clinical features of AR-JP are sometimes quite similar to those of late-onset idiopathic PD. ¹²³I-MISG myocardial scintigraphy may be a powerful tool to differentiate PD from other parkinsonian syndromes, including AR-JP.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 20`
A06				`@2 5`
A08	`01`	`1`	`ENG`	`@1 Preserved myocardial [¹²³I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report`
A11	`01`	`1`		`@1 SUZUKI (Masahiko)`
A11	`02`	`1`		`@1 HATTORI (Nobutaka)`
A11	`03`	`1`		`@1 ORIMO (Satoshi)`
A11	`04`	`1`		`@1 FUKUMITSU (Nobuyoshi)`
A11	`05`	`1`		`@1 MASAHIRO ABO (M.)`
A11	`06`	`1`		`@1 KONO (Yu)`
A11	`07`	`1`		`@1 SENGOKU (Renpei)`
A11	`08`	`1`		`@1 KURITA (Akira)`
A11	`09`	`1`		`@1 HONDA (Hidehiko)`
A11	`10`	`1`		`@1 INOUE (Kiyoharu)`
A14	`01`			`@1 Department of Neurology, The Jikei University School of Medicine @2 Tokyo @3 JPN @Z 1 aut. @Z 6 aut. @Z 7 aut. @Z 8 aut. @Z 9 aut. @Z 10 aut.`
A14	`02`			`@1 Department of Neurology, Juntendo University School of Medicine @2 Tokyo @3 JPN @Z 2 aut.`
A14	`03`			`@1 Department of Neurology, Kanto Central Hospital @2 Tokyo @3 JPN @Z 3 aut.`
A14	`04`			`@1 Department of Radiology, The Jikei University School of Medicine @2 Tokyo @3 JPN @Z 4 aut.`
A14	`05`			`@1 Department of Rehabilitation Medicine, The Jikei University School of Medicine @2 Tokyo @3 JPN @Z 5 aut.`
A20				`@1 634-636`
A21				`@1 2005`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000124690200190`
A44				`@0 0000 @1 © 2005 INIST-CNRS. All rights reserved.`
A45				`@0 12 ref.`
A47	`01`	`1`		`@0 05-0281352`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 A decrease in myocardial uptake of iodine-123-labeled metaiodobenzylguanidine (¹²³I-MIBG) has been reported in idiopathic Parkinson's disease (PD) using ¹²³I-MIBG myocardial scintigraphy. However, the patient with autosomal recessive juvenile parkinsonism (AR-JP). caused by the parkin gene, presented here showed normal ¹²³I-MIBG myocardial uptake, suggesting that AR-JP is a distinct disease entity from PD. Although the clinical features of AR-JP are sometimes quite similar to those of late-onset idiopathic PD. ¹²³I-MISG myocardial scintigraphy may be a powerful tool to differentiate PD from other parkinsonian syndromes, including AR-JP.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C02	`03`	`X`		`@0 002B17E`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Parkinsonisme @2 NM @5 02`
C03	`02`	`X`	`ENG`	`@0 Parkinsonism @2 NM @5 02`
C03	`02`	`X`	`SPA`	`@0 Parkinson síndrome @2 NM @5 02`
C03	`03`	`X`	`FRE`	`@0 Parkinson maladie @5 03`
C03	`03`	`X`	`ENG`	`@0 Parkinson disease @5 03`
C03	`03`	`X`	`SPA`	`@0 Parkinson enfermedad @5 03`
C03	`04`	`X`	`FRE`	`@0 Captation @5 09`
C03	`04`	`X`	`ENG`	`@0 Uptake @5 09`
C03	`04`	`X`	`SPA`	`@0 Captación @5 09`
C03	`05`	`X`	`FRE`	`@0 Etude cas @5 10`
C03	`05`	`X`	`ENG`	`@0 Case study @5 10`
C03	`05`	`X`	`SPA`	`@0 Estudio caso @5 10`
C07	`01`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
N21				`@1 199`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 05-0281352 INIST
ET :	Preserved myocardial [¹²³I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report
AU :	SUZUKI (Masahiko); HATTORI (Nobutaka); ORIMO (Satoshi); FUKUMITSU (Nobuyoshi); MASAHIRO ABO (M.); KONO (Yu); SENGOKU (Renpei); KURITA (Akira); HONDA (Hidehiko); INOUE (Kiyoharu)
AF :	Department of Neurology, The Jikei University School of Medicine/Tokyo/Japon (1 aut., 6 aut., 7 aut., 8 aut., 9 aut., 10 aut.); Department of Neurology, Juntendo University School of Medicine/Tokyo/Japon (2 aut.); Department of Neurology, Kanto Central Hospital/Tokyo/Japon (3 aut.); Department of Radiology, The Jikei University School of Medicine/Tokyo/Japon (4 aut.); Department of Rehabilitation Medicine, The Jikei University School of Medicine/Tokyo/Japon (5 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2005; Vol. 20; No. 5; Pp. 634-636; Bibl. 12 ref.
LA :	Anglais
EA :	A decrease in myocardial uptake of iodine-123-labeled metaiodobenzylguanidine (¹²³I-MIBG) has been reported in idiopathic Parkinson's disease (PD) using ¹²³I-MIBG myocardial scintigraphy. However, the patient with autosomal recessive juvenile parkinsonism (AR-JP). caused by the parkin gene, presented here showed normal ¹²³I-MIBG myocardial uptake, suggesting that AR-JP is a distinct disease entity from PD. Although the clinical features of AR-JP are sometimes quite similar to those of late-onset idiopathic PD. ¹²³I-MISG myocardial scintigraphy may be a powerful tool to differentiate PD from other parkinsonian syndromes, including AR-JP.
CC :	002B17; 002B17G; 002B17E
FD :	Système nerveux pathologie; Parkinsonisme; Parkinson maladie; Captation; Etude cas
FG :	Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie
ED :	Nervous system diseases; Parkinsonism; Parkinson disease; Uptake; Case study
EG :	Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease
SD :	Sistema nervioso patología; Parkinson síndrome; Parkinson enfermedad; Captación; Estudio caso
LO :	INIST-20953.354000124690200190
ID :	05-0281352

Links to Exploration step

Pascal:05-0281352

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Preserved myocardial [<sup>123</sup>
I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report</title>
<author><name sortKey="Suzuki, Masahiko" sort="Suzuki, Masahiko" uniqKey="Suzuki M" first="Masahiko" last="Suzuki">Masahiko Suzuki</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hattori, Nobutaka" sort="Hattori, Nobutaka" uniqKey="Hattori N" first="Nobutaka" last="Hattori">Nobutaka Hattori</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Neurology, Juntendo University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Orimo, Satoshi" sort="Orimo, Satoshi" uniqKey="Orimo S" first="Satoshi" last="Orimo">Satoshi Orimo</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, Kanto Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fukumitsu, Nobuyoshi" sort="Fukumitsu, Nobuyoshi" uniqKey="Fukumitsu N" first="Nobuyoshi" last="Fukumitsu">Nobuyoshi Fukumitsu</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Radiology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Masahiro Abo, M" sort="Masahiro Abo, M" uniqKey="Masahiro Abo M" first="M." last="Masahiro Abo">M. Masahiro Abo</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Rehabilitation Medicine, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kono, Yu" sort="Kono, Yu" uniqKey="Kono Y" first="Yu" last="Kono">Yu Kono</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sengoku, Renpei" sort="Sengoku, Renpei" uniqKey="Sengoku R" first="Renpei" last="Sengoku">Renpei Sengoku</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kurita, Akira" sort="Kurita, Akira" uniqKey="Kurita A" first="Akira" last="Kurita">Akira Kurita</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Honda, Hidehiko" sort="Honda, Hidehiko" uniqKey="Honda H" first="Hidehiko" last="Honda">Hidehiko Honda</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Inoue, Kiyoharu" sort="Inoue, Kiyoharu" uniqKey="Inoue K" first="Kiyoharu" last="Inoue">Kiyoharu Inoue</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0281352</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0281352 INIST</idno>
<idno type="RBID">Pascal:05-0281352</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001E83</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Preserved myocardial [<sup>123</sup>
I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report</title>
<author><name sortKey="Suzuki, Masahiko" sort="Suzuki, Masahiko" uniqKey="Suzuki M" first="Masahiko" last="Suzuki">Masahiko Suzuki</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hattori, Nobutaka" sort="Hattori, Nobutaka" uniqKey="Hattori N" first="Nobutaka" last="Hattori">Nobutaka Hattori</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Neurology, Juntendo University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Orimo, Satoshi" sort="Orimo, Satoshi" uniqKey="Orimo S" first="Satoshi" last="Orimo">Satoshi Orimo</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, Kanto Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fukumitsu, Nobuyoshi" sort="Fukumitsu, Nobuyoshi" uniqKey="Fukumitsu N" first="Nobuyoshi" last="Fukumitsu">Nobuyoshi Fukumitsu</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Radiology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Masahiro Abo, M" sort="Masahiro Abo, M" uniqKey="Masahiro Abo M" first="M." last="Masahiro Abo">M. Masahiro Abo</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Rehabilitation Medicine, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kono, Yu" sort="Kono, Yu" uniqKey="Kono Y" first="Yu" last="Kono">Yu Kono</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sengoku, Renpei" sort="Sengoku, Renpei" uniqKey="Sengoku R" first="Renpei" last="Sengoku">Renpei Sengoku</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kurita, Akira" sort="Kurita, Akira" uniqKey="Kurita A" first="Akira" last="Kurita">Akira Kurita</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Honda, Hidehiko" sort="Honda, Hidehiko" uniqKey="Honda H" first="Hidehiko" last="Honda">Hidehiko Honda</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Inoue, Kiyoharu" sort="Inoue, Kiyoharu" uniqKey="Inoue K" first="Kiyoharu" last="Inoue">Kiyoharu Inoue</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Case study</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Parkinsonism</term>
<term>Uptake</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Parkinsonisme</term>
<term>Parkinson maladie</term>
<term>Captation</term>
<term>Etude cas</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A decrease in myocardial uptake of iodine-123-labeled metaiodobenzylguanidine (<sup>123</sup>
I-MIBG) has been reported in idiopathic Parkinson's disease (PD) using <sup>123</sup>
I-MIBG myocardial scintigraphy. However, the patient with autosomal recessive juvenile parkinsonism (AR-JP). caused by the parkin gene, presented here showed normal <sup>123</sup>
I-MIBG myocardial uptake, suggesting that AR-JP is a distinct disease entity from PD. Although the clinical features of AR-JP are sometimes quite similar to those of late-onset idiopathic PD. <sup>123</sup>
I-MISG myocardial scintigraphy may be a powerful tool to differentiate PD from other parkinsonian syndromes, including AR-JP.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>20</s2>
</fA05>
<fA06><s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Preserved myocardial [<sup>123</sup>
I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SUZUKI (Masahiko)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>HATTORI (Nobutaka)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>ORIMO (Satoshi)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>FUKUMITSU (Nobuyoshi)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>MASAHIRO ABO (M.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>KONO (Yu)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>SENGOKU (Renpei)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>KURITA (Akira)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>HONDA (Hidehiko)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>INOUE (Kiyoharu)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Neurology, Juntendo University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, Kanto Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Radiology, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Rehabilitation Medicine, The Jikei University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>634-636</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000124690200190</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>12 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>05-0281352</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>A decrease in myocardial uptake of iodine-123-labeled metaiodobenzylguanidine (<sup>123</sup>
I-MIBG) has been reported in idiopathic Parkinson's disease (PD) using <sup>123</sup>
I-MIBG myocardial scintigraphy. However, the patient with autosomal recessive juvenile parkinsonism (AR-JP). caused by the parkin gene, presented here showed normal <sup>123</sup>
I-MIBG myocardial uptake, suggesting that AR-JP is a distinct disease entity from PD. Although the clinical features of AR-JP are sometimes quite similar to those of late-onset idiopathic PD. <sup>123</sup>
I-MISG myocardial scintigraphy may be a powerful tool to differentiate PD from other parkinsonian syndromes, including AR-JP.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17E</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Parkinsonisme</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Parkinsonism</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Parkinson síndrome</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Captation</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Uptake</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Captación</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Case study</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>199</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 05-0281352 INIST</NO>
<ET>Preserved myocardial [<sup>123</sup>
I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report</ET>
<AU>SUZUKI (Masahiko); HATTORI (Nobutaka); ORIMO (Satoshi); FUKUMITSU (Nobuyoshi); MASAHIRO ABO (M.); KONO (Yu); SENGOKU (Renpei); KURITA (Akira); HONDA (Hidehiko); INOUE (Kiyoharu)</AU>
<AF>Department of Neurology, The Jikei University School of Medicine/Tokyo/Japon (1 aut., 6 aut., 7 aut., 8 aut., 9 aut., 10 aut.); Department of Neurology, Juntendo University School of Medicine/Tokyo/Japon (2 aut.); Department of Neurology, Kanto Central Hospital/Tokyo/Japon (3 aut.); Department of Radiology, The Jikei University School of Medicine/Tokyo/Japon (4 aut.); Department of Rehabilitation Medicine, The Jikei University School of Medicine/Tokyo/Japon (5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2005; Vol. 20; No. 5; Pp. 634-636; Bibl. 12 ref.</SO>
<LA>Anglais</LA>
<EA>A decrease in myocardial uptake of iodine-123-labeled metaiodobenzylguanidine (<sup>123</sup>
I-MIBG) has been reported in idiopathic Parkinson's disease (PD) using <sup>123</sup>
I-MIBG myocardial scintigraphy. However, the patient with autosomal recessive juvenile parkinsonism (AR-JP). caused by the parkin gene, presented here showed normal <sup>123</sup>
I-MIBG myocardial uptake, suggesting that AR-JP is a distinct disease entity from PD. Although the clinical features of AR-JP are sometimes quite similar to those of late-onset idiopathic PD. <sup>123</sup>
I-MISG myocardial scintigraphy may be a powerful tool to differentiate PD from other parkinsonian syndromes, including AR-JP.</EA>
<CC>002B17; 002B17G; 002B17E</CC>
<FD>Système nerveux pathologie; Parkinsonisme; Parkinson maladie; Captation; Etude cas</FD>
<FG>Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie</FG>
<ED>Nervous system diseases; Parkinsonism; Parkinson disease; Uptake; Case study</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Sistema nervioso patología; Parkinson síndrome; Parkinson enfermedad; Captación; Estudio caso</SD>
<LO>INIST-20953.354000124690200190</LO>
<ID>05-0281352</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E83 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001E83 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:05-0281352
   |texte=   Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report

Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism : First case report

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri